PD318088
PD318088 is a potent, allosteric and non-ATP competitive MEK1/2 inhibitor, an analog of PD184352. PD318088 binds simultaneously with ATP in a region of the MEK1 active site that is adjacent to the ATP-binding site. PD318088 can be used for cancer research[1].
Product Specifications
CAS Number
391210-00-7
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
MEK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/PD318088.html
Purity
99.82
Solubility
DMSO : ≥ 100 mg/mL
Smiles
BrC1=CC(C(NOCC(CO)O)=O)=C(C(F)=C1F)NC2=CC=C(C=C2F)I
Molecular Formula
C16H13BrF3IN2O4
Molecular Weight
561.09
Precautions
H302, H315, H319, H335
References & Citations
[1]Ohren JF, et al. Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition. Nat Struct Mol Biol. 2004 Dec;11 (12) :1192-7.|[2]Han S, et al. Identification of coumarin derivatives as a novel class of allosteric MEK1 inhibitors. Bioorg Med Chem Lett. 2005 Dec 15;15 (24) :5467-73.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
MEK1; MEK2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb1477026-01 100 µg
Severe acute respiratory syndrome coronavirus 2 Nucleoprotein Protein
Sign In for Pricing
View Details orb1477026-02 1 mg
Severe acute respiratory syndrome coronavirus 2 Nucleoprotein Protein
Sign In for Pricing
View Details SR304779 2 nmol
TEK (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
Sign In for Pricing
View Details 